The Immunotherapy of Cancer Conference (ITOC) is a European meeting providing a global platform for translational research in the field of immuno-oncology as well as a forum for discussion of early clinical translation and to address its unique challenges.
ITOC takes place for the 10th tim in Munich:
- when: March 21 - 23, 2024
- where: Klinikum der Universität München, Campus Großhadern, Marchioninistrasse 15, 81377 Munich, Germany
ITOC is organised by the WMA GmbH in scientific cooperation with the ITOC Association, the Tumor Centre in Munich (TZM), the Wolfgang Wilmanns Stiftung (WWS), the German Cancer Consortium (DKTK), the Chinese American Hematologist and Oncologist Network (CAHON) as well as the Comprehensive Cancer Center Munich (CCCM) in Munich.
The main goal of the series of ITOC conferences is to provide a unique platform for discussions where all those dedicated to the immunotherapy of cancer can exchange their knowledge and latest findings to advance the oncology drug development and delivery.
More information on program and registration can be found at:
ITOC - 10th Immunotherapy of Cancer Conference